Email this article SENSITIVITY OF 2018 KAZAKHSTAN INFLUENZA TYPE B VIRUSES TO ANTIVIRAL DRUGS
- Authors: Lukmanova G.V.1, Klivleyeva N.G.1, Baimukhametova A.M.1, Ongarbayeva N.S.1, Kalkozhayeva M.K.1, Baiseiit S.B.1, Glebova T.I.1
-
Affiliations:
- LLP Sсientific Production Center for Microbiology and Virology, Almaty
- Issue: Vol 8, No 4 (2018)
- Pages: 531
- Section: VIRAL INFECTIONS MANAGED BY MEANS OF VACCINATION AT THE STAGE OF DESTRUCTION AND ELIMINATION
- Submitted: 23.12.2018
- Accepted: 23.12.2018
- Published: 30.12.2018
- URL: https://iimmun.ru/iimm/article/view/919
- DOI: https://doi.org/10.15789/2220-7619-2018-4-3.31
- ID: 919
Cite item
Full Text
Abstract
About the authors
G. V. Lukmanova
LLP Sсientific Production Center for Microbiology and Virology, Almaty
Author for correspondence.
Kazakhstan
N. G. Klivleyeva
LLP Sсientific Production Center for Microbiology and Virology, AlmatyKazakhstan
A. M. Baimukhametova
LLP Sсientific Production Center for Microbiology and Virology, AlmatyKazakhstan
N. S. Ongarbayeva
LLP Sсientific Production Center for Microbiology and Virology, AlmatyKazakhstan
M. K. Kalkozhayeva
LLP Sсientific Production Center for Microbiology and Virology, AlmatyKazakhstan
S. B. Baiseiit
LLP Sсientific Production Center for Microbiology and Virology, AlmatyKazakhstan
T. I. Glebova
LLP Sсientific Production Center for Microbiology and Virology, AlmatyKazakhstan
Supplementary files
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).